Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment

More here:
Brickell Biotech Reports Results from U.S. Phase 3 Open-Label, Long-Term Safety Study on Chronic Use of Sofpironium Bromide Gel as a Potential...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh